Precipio Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Precipio.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 20.9% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost
Aug 21Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet
Jun 07Investors Holding Back On Precipio, Inc. (NASDAQ:PRPO)
Mar 29Precipio, Inc.'s (NASDAQ:PRPO) Subdued P/S Might Signal An Opportunity
Aug 29Precipio to distribute HemeScreen through Fisher Healthcare channel
Jul 20Precipio terminates its equity line with Lincoln Park
Jun 15We Think Some Shareholders May Hesitate To Increase Precipio, Inc.'s (NASDAQ:PRPO) CEO Compensation
Jun 12Precipio shares surge on HemeScreen Anemia Panel launch
Jun 08Precipio shares surge on launching hemescreen panel for Acute Myeloid Leukemia
May 10Precipio: COVID-19 Testing At Amazon Is An Impressive Yet Transitory Fluke
May 05Precipio shares jump on launching its rapid COVID-19 antibody test on Amazon platform
May 03In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Precipio has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 17 | -3 | 0 | 0 | N/A |
6/30/2024 | 17 | -4 | -1 | -1 | N/A |
3/31/2024 | 16 | -5 | -3 | -3 | N/A |
12/31/2023 | 15 | -6 | -4 | -4 | N/A |
9/30/2023 | 13 | -9 | -5 | -5 | N/A |
6/30/2023 | 11 | -11 | -7 | -7 | N/A |
3/31/2023 | 10 | -11 | -7 | -7 | N/A |
12/31/2022 | 9 | -12 | -8 | -8 | N/A |
9/30/2022 | 9 | -12 | -8 | -8 | N/A |
6/30/2022 | 9 | -11 | -8 | -8 | N/A |
3/31/2022 | 9 | -12 | -8 | -8 | N/A |
12/31/2021 | 9 | -9 | -7 | -7 | N/A |
9/30/2021 | 8 | -8 | -7 | -7 | N/A |
6/30/2021 | 8 | -10 | -7 | -7 | N/A |
3/31/2021 | 7 | -9 | -7 | -7 | N/A |
12/31/2020 | 6 | -14 | -8 | -7 | N/A |
9/30/2020 | 5 | -16 | -8 | -8 | N/A |
6/30/2020 | 4 | -14 | -8 | -8 | N/A |
3/31/2020 | 4 | -18 | -9 | -9 | N/A |
12/31/2019 | 3 | -13 | -9 | -9 | N/A |
9/30/2019 | 3 | -16 | -9 | -9 | N/A |
6/30/2019 | 3 | -18 | -8 | -8 | N/A |
3/31/2019 | 3 | -16 | -8 | -7 | N/A |
12/31/2018 | 3 | -20 | -7 | -7 | N/A |
9/30/2018 | 3 | -26 | -7 | -7 | N/A |
6/30/2018 | 3 | -33 | N/A | -9 | N/A |
3/31/2018 | 2 | -38 | N/A | -8 | N/A |
12/31/2017 | 2 | -33 | N/A | -7 | N/A |
9/30/2017 | 1 | -21 | N/A | -5 | N/A |
6/30/2017 | 1 | -11 | N/A | -1 | N/A |
3/31/2017 | 1 | -3 | N/A | -1 | N/A |
12/31/2016 | 2 | -4 | N/A | -1 | N/A |
12/31/2015 | 1 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PRPO's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if PRPO's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if PRPO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PRPO's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if PRPO's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PRPO's Return on Equity is forecast to be high in 3 years time